Commercial and solution-oriented legal advice

Equity capital markets play a crucial role in the financial ecosystem, enabling companies to raise capital essential for growth, innovation or restructuring. We're dedicated to guiding companies (and their advisers) through the complexities of listing shares on public markets, raising capital and complying with the regulatory environment that governs public companies. 

Navigating the equity capital markets involves challenges such as fluctuating market conditions, stringent regulatory requirements, and the need for strategic planning. Our experienced team is adept at scoping, structuring and delivering transactions to anticipate and address these issues, providing advice which maximises value, minimises risk and avoids delays.

This team provides a first-class service. They are very quick to help, provide excellent advice and are very proactive and commercial as well

Equity capital markets client, Legal 500

How we can help you

We advise issuers, financial institutions and other market participants on all aspects of equity capital markets transactions, including:

  • initial public offerings on local and international stock exchanges;
  • follow-on offerings, including placings, rights issues, open offers and capitalisations;
  • block trades;
  • capital reorganisations;
  • demergers; and
  • share buy-back programmes.

We also advise on public M&A, all aspects of associated corporate governance and regulatory requirements.

Our capital equity markets lawyers

Our international team works with clients across the value range and we seek to form lasting, trusted adviser relationships throughout their lifecycle as a quoted company. We're particularly strong in the mid-market and are ranked consistently highly in the legal directories for our corporate practice.

Clients choose us for our partner-led service, where partners are actively engaged in and manage deal processes. We pride ourselves on being commercial and solution-oriented, working 'with' our clients to build long-term relationships. Supported by colleagues across the firm (including Employment, Commercial, Incentives, Tax, Banking, and Real Estate), we offer comprehensive support to meet all your needs.

Experience

Creo Medical Group PLC

Advised Creo Medical Group PLC, an AIM-quoted medical devices company focusing on the emerging field of surgical endoscopy, on multiple fundraises since 2018, raising an aggregate amount in excess of £170m.

Elixirr International plc

Advised Elixirr, the established, global, award-winning, challenger consultancy, on its successful £98m AIM IPO.

Learn more
Cenkos Securities plc

Acting for Cenkos on the £150m AIM IPO of Lords Group Trading plc, a leading distributor of building materials in the UK.

Investec

Advised Investec on £40m placing for Distribution Finance Capital Holdings plc, a specialist bank providing working capital solutions to dealers and manufacturers across the UK.

Learn more
BioSenic

Advised the listed company BioSenic on its reversed merger with the French company Medsenic as well as various private placement of shares and convertible bond programs.

TiGenix

Advised TiGenix, an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, on its NASDAQ listing and subsequent €520m sale to Takeda.

Singer Capital Markets

Advised Singer Capital Markets on the move by Chapel Down Group plc, England's leading and largest wine producer with an award-winning range of sparkling and still wines, to AIM from the Aquis Stock Exchange.

Learn more